| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_XPO1_0006700 | Exon-Exon | chr2:61712903-61717911 | chr2:61485768-61490776 | 621 nt | 0.3816 |
| hsa_XPO1_0006800 | Exon-Exon | chr2:61712903-61720188 | chr2:61485768-61493053 | 1263 nt | 0.3721 |
| hsa_XPO1_0006900 | Exon-Exon | chr2:61712903-61724142 | chr2:61485768-61497007 | 1749 nt | 0.3716 |
| hsa_XPO1_0007000 | Exon-Exon | chr2:61712903-61725927 | chr2:61485768-61498792 | 1869 nt | 0.3708 |
| hsa_XPO1_0007100 | Exon-Exon | chr2:61712903-61726048 | chr2:61485768-61498913 | 1918 nt | 0.3702 |
| hsa_XPO1_0007200 | Exon-Exon | chr2:61712903-61727029 | chr2:61485768-61499894 | 2100 nt | 0.3695 |
| hsa_XPO1_0007300 | Exon-Exon | chr2:61712903-61729445 | chr2:61485768-61502310 | 2207 nt | 0.3684 |
| hsa_XPO1_0007400 | Intron-Exon-Intron | chr2:61712903-61752468 | chr2:61485768-61525333 | 250 nt | 0.3200 |
| hsa_XPO1_0007500 | Exon-Exon | chr2:61712903-61753656 | chr2:61485768-61526521 | 2382 nt | 0.3686 |
| hsa_XPO1_0007600 | Exon-Exon | chr2:61712903-61761038 | chr2:61485768-61533903 | 2514 nt | 0.3707 |
A study in humans demonstrated that circXPO1 is highly expressed in early stages of hepatocellular carcinoma, bladder cancers, and breast cancer, and its decreased expression in myocardial tissues is associated with improved cardiac function after acute myocardial infarction [Sema Misir et al. DOI:10.1038/s41418-022-00948-7]. A study in human coronary artery samples from a single autopsy case demonstrated that circXPO1 was identified as a co-overexpressed circRNA in both the left anterior descending and right coronary artery samples, classifying it as a potential biomarker associated with coronary atherosclerosis [Hou et al. DOI:10.1002/jcla.23552].